Herts and Essex Fertility - IVF Spot Purchase NCL ICB

The procurement process for the "Herts and Essex Fertility - IVF Spot Purchase NCL ICB" has been completed and resulted in a contract award. The buyer, NHS North Central London ICB, headquartered in London, awarded the contract under the Health Care Services (Provider Selection Regime) Regulations 2023, which are outside the Public Contracts Regulations 2015. The procurement relates to in vitro fertilisation services, classified under the healthcare industry, with the service delivered in the UK region UKH2.

The contract was signed on 7th August 2025, and the procurement method was a limited procedure without prior publication of a call for competition, aimed at fostering patient choice for fertility treatment providers. This tender presents significant business growth opportunities for specialised healthcare service providers, particularly those focusing on fertility treatments. The process's streamlined nature through a Provider Selection Regime Direct Award suggests a potential interest in unique or innovative service offerings that can complement existing solutions.

Businesses that are well-versed in navigating the NHS procurement landscape and that have the capability to deliver high-quality IVF services may find this type of procurement beneficial for expanding their reach within the public healthcare sector.